Antihypertensive Effect of Galegine from <i>Biebersteinia heterostemon</i> in Rats

• Main Authors: Weien Wang, Xiaofeng Zhang
• Format: Article
• Language: English
• Published: MDPI AG 2021-08-01
• Series: Molecules
• Subjects: <i>Biebersteinia heterostemon</i>; galegine; hypotensive; toxicity
• Online Access: https://www.mdpi.com/1420-3049/26/16/4830

The aerial part of <i>Biebersteinia heterostemon</i> Maxim. (Geraniaceae Biebersteiniaceae) known as <i>ming jian na bao</i> in Chinese, has been traditionally used in Tibetan folk medicine for treatment of diabetes and hypertension. The aim of the present study was to evaluate the effects of galegine obtained from an ethanol extract of the entire <i>Biebersteinia heterostemon</i> plant on the rat’s cardiovascular system in order to characterize its contributions as an antihypertensive agent. The antihypertensive effect of galegine was investigated in pentobarbital-anesthetized hypertensive rats at three dose levels based on the LD₅₀ of galegine. Meanwhile a positive control group received dimaprit with the same procedure. Dimaprit infusion induced a significant hypotension which declined by an average margin of 20%. Simultaneously, single administration of galegine at the doses of 2.5, 5, and 10 mg/kg by intraperitoneal injection induced an immediate and dose-dependent decrease in mean arterial blood pressure (MABP) by an average margin of 40% with a rapid increase in heart rate (HR). We demonstrated that galegine is effective in reducing blood pressure in anesthetized hypertensive rats with rapid onset and a dose-related duration of the effects. The results indicate that galegine was the bioactive compound which can be used as a pharmacophore to design new hypertensive agents.